Regentis Biomaterials RGNT
NYSE RGNT
$1.50 +0.03 (+2.41%)
As of: Oct 21, 2026 · 3:51 PM EDT

Regentis Biomaterials (RGNT) Market Capitalization (2025 - 2026)

Updated

Regentis Biomaterials (RGNT) recorded Market Capitalization of $2 million in Q2 2026.

Analysis

Regentis Biomaterials (RGNT) Market Capitalization (2025 - 2026) Analysis & Trends

For FY2025, Regentis Biomaterials reported Market Capitalization of $3.82 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 257.99 Bn 237.02 Bn 4.88 Bn
2 Abbott Laboratories 175.01 Bn 145.44 Bn 7.27 Bn
3 Danaher 164.93 Bn 148.74 Bn 3.61 Bn
4 Intuitive Surgical 151.84 Bn 131.26 Bn 1.96 Bn
5 Medtronic 119.05 Bn 84.30 Bn 6.34 Bn
6 Stryker 113.89 Bn 100.00 Bn 4.50 Bn
7 Boston Scientific 65.37 Bn 60.13 Bn 3.85 Bn
8 Becton Dickinson 53.36 Bn 50.51 Bn 2.32 Bn
9 Edwards Lifesciences 50.83 Bn 34.83 Bn 1.35 Bn
10 Regentis Biomaterials 852,949.72 852,949.72 -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 18.28 Mn
Dec 31, 2025 34.91 Mn
API Access

Regentis Biomaterials Market Capitalization API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=market-capitalization&ticker=RGNT&period=max&api_key=YOUR_API_KEY